Targeting the Extracellular Matrix: Overcoming Biological Barriers to Unlock Novel Therapeutic Opportunities
- Analyzing why components of the extracellular matrix (ECM) could be ideal targets for radioligand therapy
- Exploring challenges associated with delivering therapeutic doses when targeting components of the ECM
- Reviewing early development strategy for a novel fibrin targeted radioligand therapy
New Company for 2026